Surveillance of multi-resistant microrganisms and epidemiological investigation of intensive care unit patients
Análise de parâmetros relevantes em culturas de vigilância epidemiológica de pacientes internados no centro de tratamento intensivo e colonizados por microrganismos multirresistentes
DOI:
https://doi.org/10.34117/bjdv8n12-204Keywords:
health care-related infections, active surveillance cultures, multidrug-resistant microorganisms, intensive care centerAbstract
It is of great importance to detect the presence of microorganisms in healthcare services. On this basis, strategies should be developed to maintain safety inside the hospital environment by preventing the transmission of microorganisms, thus preventing healthcare-associated infections (HAI). In the Intensive Care Unit (ICU), the precocious detection of infection and/or colonization by multidrug-resistant (MDR) microorganisms is key. For this reason, the routine monitoring of patients that are infected or colonized by MDR microorganisms is mandatory. In this context, this study aimed to evaluate the performance of epidemiological surveillance swabs and microbiological cultures in ICU patients in a university public hospital in Belo Horizonte, Minas Gerais State, Brazil. Medical records of patients admitted to the ICU from January 1st, 2018 to December 31st, 2020, submitted to epidemiological surveillance cultures, and presenting factors correlated to the development of HAI were evaluated. This was a descriptive, retrospective and observational, non-interventional study. The study population was composed mainly of male patients (66.3%), with a mean age of 59 years, coming from the Medical Clinic department, and septicemia was the main cause of hospitalization in the ICU. The analyses showed that 9.5% of the patients were colonized by MDR microorganisms. The samples were collected at the ICU, and a higher frequency of gram-negative bacteria was observed, including A. baumannii, P. aeruginosa, K. pneumoniae, and carbapenem-resistant Enterobacteriaceae. The most frequently prescribed antimicrobials were β-lactams and glycopeptides, and the same patient was treated using more than one class of antimicrobials. The surveillance culture is key to understanding the microbiological profile of the institution. The collection of swabs and microbiological cultures from different sites could be used to adopt routines and recommend measures aimed at controlling and reducing the HAI rates as well as the emergence of MDR outbreaks. These procedures could contribute to the creation and maintenance of a safe and effective healthcare service.
References
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. ANVISA. MS. Critérios Diagnósticos de Infecções Relacionadas à Assistência à Saúde/Agência Nacional de Vigilância Sanitária. Brasília-DF: 2017.
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. ANVISA. MS. Nota técnica GVIMS/GGTES n. 04/2019. Encaminhamento de isolados para a Sub-rede Analítica de Resistência Microbiana nas situações de surtos de IRAS nos serviços de saúde. Brasília-DF: 2019.
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. ANVISA. MS. Nota técnica GVIMS/GGTES n. 07/2021. Critérios diagnósticos das Infecções Relacionadas à Assistência à Saúde (IRAS): notificação nacional obrigatória para o ano de 2022. Brasília-DF: 2021.
ALMEIDA, T.; LOURENÇO, M. L. Envelhecimento, Amor e Sexualidade: utopia ou realidade? Revista Brasileira de Geriatria e Gerontologia, V.10, N.1, 101-113 p., 2007.
ARCANJO, R. A. Monitorização de pacientes para microrganismos resistentes em uma unidade de terapia intensiva: uma análise da incidência e dos fatores associados. Escola de Enfermagem. UFMG. Tese de dissertação. 106 p., 2014.
BABADY, N. E. et al. Performance Characteristics of the Cepheid Xpert vanA Assay for rapid identification of patients at high risk for carriage of Vancomycin-Resistant Enterococci. Journal Clinical Microbiology: V.50, N.11. 3659-63 p., 2012.
BUTLER-LAPORTE, G.; DE L’ÉTOILE-MOREL, S.; CHENG, M. P. et al. MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis. J. Infect. V. 77 (6): 489-495 p., 2018.
CENTER FOR DISEASE CONTROL AND PREVENTION. CDC. Healthcare-associated Infections. Progress Report, 2016. Disponível em: < https://www.cdc.gov/HAI/pdfs/progressreport/hai-progress-report.pdf >.
CENTER FOR DISEASE CONTROL AND PREVENTION. CDC. National Healthcare Safety Network (NHSN). Patient Safety Component Manual. 1-355 p., 2019. Disponível em: < https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf >.
COLLINGTON, P. J; MCEWEN, S. A. One Health- Its Importance in Helping to Better Control Antimicrobial Resistance. Trop. Med. Infect. Dis. V. 4 (1): 22 p., 2019. DOI: 10.3390/tropicalmed4010022.
COSTA, M. M. M. Efeitos de um ciclo de melhoria da qualidade nacional aplicado à estruturação das ações de prevenção das infecções relacionadas à assistência à saúde em hospitais brasileiros, 2016. 124f. Dissertação (Mestrado Profissional em Gestão da Qualidade em Serviços de Saúde) - Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte: Natal, 2016.
FERREIRA, J.; BOUZADA, M. C. F.; JESUS, L. A.; CORTES, M. C. W.; ARMOND, G. A.; CLEMENTE, W. T.; ANCHIETA, L. M.; ROMANELLI, R. M. C. Evaluation of national health-care related infection criteria for epidemiological surveillance in neonatology. J. Pediatr: Rio de Janeiro. V. 90, 389-95 p., 2014.
FORTALEZA, C. M. B.; FREITAS, F. M; LAUTERBACH, G. P. Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil. American Journal Infection Control, V.41, 263-265 p., 2013.
FURTADO, G. H. et al. Bloodstream infections with OXA-23-producing Acinetobacter baumannii isolates in a university-affiliated hospital in Brazil: epidemiology and clinical outcomes. Am. J. Infect Control: V. 39, N. 8, 706-708 p., 2011.
GIRARDELLO, R.; VISCONDE, M.; CAYO, R.; DE FIGUEIREDO, R.; MORI, M.; LINCOPAN, N. Diversidade dos mecanismos de resistência à polimixina entre isolados clínicos de Acinetobacter baumannii. Diagn. Microbiol. Infectar. Dis. V. 87, 37-44 p., 2017. DOI: 10.1016 / j. diagmicrobio.2016.10.011.
GOMES, A. C. et al. Caracterização das Infecções Relacionadas à Assistência à Saúde em unidade de terapia intensiva. Rev. Enferm. UFPE On Line, Recife, V. 6, N. 8, 1577-1585 p., 2014.
HARRIS, A.D. et al. Targeted surveillance of methicillin- resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother. V. 54, n.8, p. 3134-3138, 2010.
HESPANHOL, L. A. B. et al. Infección relacionada con la Asistencia a la Salud en Unidad de Cuidados Intensivos Adulto. Enfermería global, V. 18, N. 1, 215-254 p., 2018.
HOSPITAL RISOLETA TOLENTINO NEVES. HRTN: 2022. Site: https://www.hrtn.fundep.ufmg.br
JACKSON; S. S.; HARRIS, A. D.; MAGDER, L. S.; STAFFORD, K. A.; JOHNSON, J. K.; MILLER, L. G.; CALFEE, D. P.; THOM, K. A.; CDC, P. E. Bacterial burden is associated with increased transmission to health care workers from patients colonized with vancomycin resistant Enterococcus. Am. J. Infect Control. V. 47 (1): 13-17 p., 2019. DOI: 10.1016/j.ajic.2018.07.011.
JONES, R. N. et al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). The Brazilian Journal of Infectious Diseases, V. 17, N. 6, 672-681 p., 2013.
KEMPF, M.; ROLAIN, J. M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. International Journal Antimicrobial Agents, V. 39, 105-114 p., 2012.
KWIECINSKI, J. M.; HORSWILL, A. R. Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms. Current Opinion in Microbiology. V. 53: 51-60 p., 2020.
LABARCA, J. A.; SALLES, M. J.; SEAS, C. et al. Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Crit. Rev Microbiol.: V. 42 (2), 276-292 p., 2014.
LACERDA, M. K. S.; SOUZA, S. C. O.; SOARES, D. M.; SILVEIRA, B. R. M.; LOPES, J. R. Precauções padrão e Precauções Baseadas na Transmissão de doenças: revisão de literatura. Ver. Epidemiol. Control Infect. V. 4, N. 4, 254-259 p., 2014.
LIMA-COSTA, M. F.; VERAS, R. Saúde pública e envelhecimento. Cadernos de Saúde Pública, V.19, 700-701 p., 2003.
LIU, Q. et al. Risk and prognostic factors for multidrug-resistant Acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of West China. V. 10, N. 6, p. e0130701, 2015. Doi: https://doi.org/10.1371/journal.pone.0130701.
LIU, P.; LI, X.; LUO, M.; XU, X.; SU, K.; CHEN, S.; QING, Y.; LI, Y. Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis. J. Microb. Drug Resist. V. 24 (2), 190-198 p., 2018. DOI: 10.1089/mdr.2017.0061.
MARDANI, M. Editorial commentary. Worldwide attention to resistant bacteria. Iranian Journal of Clinical Infectious Disease, V. 4, N. 1, 1-2 p., 2009.
MARKOGIANNAKIS, H. et al. Infections in a surgical intensive care unit of a University Hospital in Greece. Int. J. Infect. Dis.: V. 13, N. 2, 145-153 p., 2009.
MARZEC, N. S.; BESSESEN, M. T. Risk and outcomes of methicillin- Staphylococcus aureus (MRSA) bacteremia among patients admitted with and without MRSA nares colonization. Am J. Infect Control. V. 44 (4): 405- 408 p., 2016.
MORAES, G. M. et al. Infecção ou colonização por micro-organismos resistentes: identificação de preditores. Acta paulista de Enfermagem, V.26, N.2, 185-191 p., 2013.
MOUSTAFA, A. M.; LAL, A.; Planet, P. J. Comparative genomics in infectious disease Current Opinion in Microbiology. V. 53: 61-70 p., 2020.
MURRAY, P. R.; ROSENTHAL, K. S.; PFALLER, M. A. Microbiologia médica. 8. ed. Rio de Janeiro: Elsevier; 2017.
OLIVEIRA, A. C. O.; PAULA, A. O.; IQUIAPAZA, R.; GAMA, C. S. Perfil dos microrganismos associados a colonização e infecção em terapia intensiva. Revista de Epidemiologia e Controle de Infecção, Santa Cruz do Sul. V. 7, N. 2, 101-106 p., 2017.
OLIVER, C. A.; BLAKE, R. K.; STEED, L. L. Risk of vancomycin resistant Enterococcus bloodstream infection among colonized individuals. Infection Control Hospital Epidemiology, V.29, 404-409 p., 2008.
PARAJULI, N. P.; ACHARYA, S. P.; MISHRA, S. K.; PARAJULI, K.; RIJAL, B. P.; POKHREL, B. M. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrobial Resistance & Infection Control. V. 6, N. 67, 2017.
PHILMON, C.; SMITH, T.; WILLIAMSON, S.; GOODMAN E. Controlling Use of Antimicrobials in a Community Teaching Hospital. Infect Control Hosp. Epidemiol. V. 27: 239-244 p., 2006.
PIRES, M. C. S.; FROTA, K. S.; JUNIOR, P. O. M.; CORREIA, A. F.; CORTEZ-ESCALANTE, J. J.; SILVEIRA, C. A. Prevalência e suscetibilidades bacterianas das infecções comunitárias do trato urinário, em Hospital Universitário de Brasília, no período de 2001 a 2005. Revista da Sociedade Brasileira de Medicina Tropical. V. 40, N.6, 643-7 p., 2007.
ROMANO, A.; ATANASKOVIC-MARKOVIC, M.; BARBAUD, A.; BIRCHER, A. J.; BROCKOW, K.; CAUBET, J. C. et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams – an EAACI position paper. Allergy. V. 75 (6): 1.300-15 p., 2020.
VIDERMAN, D. et al. An observational case study of hospital associated infections in a critical care unit in Astana, Kazakhstan. Antimicrobial Resistance and Infection Control, London, V. 7, N. 57, 1-9 p., 2018. Doi: https://doi: 10.1186/s13756-018-0350-0.
VINCENT, J. L. The Clinical Challenge of Sepsis Identification and Monitoring. PLoS Med. 13(5): e1002022. 2016. doi:10.1371/journal.pmed.1002022
WORLD HEALTH ORGANIZATION. WHO. World Alliance for patient Safety. WHO guidelines on hand hygiene in health care. First global patient safety challenge clean care is safer care. Geneva, 2009.
ZHANG, X. et al. Identification of a genetic determinant in clinical Enterococcus faecium strains that contributes to intestinal colonization during antibiotic treatment. Journal Infection Disease, V. 207, 1.780-1.786 p., 2013.
